Project title
PTDC/BIM-MEC/0913/2012
Code
A2AR_GLAUCO - From neuroinflammation control to neuroprotection: blocking adenosine A2A receptor for the treatment of glaucoma
 

Publications
(All)

Refined By:
Date Issued:  [2000 TO 2024]
Subject:  Inflammation

Results 1-4 of 4 (Search time: 0.004 seconds).

Issue DateTitleAuthor(s)TypeAccess
110-Jun-2015Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressureMadeira, Maria H. ; Elvas, Filipe ; Boia, Raquel ; Gonçalves, Francisco Q. ; Cunha, Rodrigo A. ; Ambrósio, A. Francisco ; Santiago, Ana Raquel articleopenAccess
28-Jun-2016Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucomaMadeira, Maria H. ; Ortin-Martinez, Arturo; Nadal-Nícolas, Francisco; Ambrósio, António F. ; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta; Santiago, Ana Raquel articleopenAccess
32015Contribution of microglia-mediated neuroinflammation to retinal degenerative diseasesMadeira, Maria H. ; Boia, Raquel ; Santos, Paulo ; Ambrósio, A. Francisco ; Santiago, Ana R. articleopenAccess
45-Oct-2017Treatment with A2A receptor antagonist KW6002 and caffeine intake regulate microglia reactivity and protect retina against transient ischemic damageBoia, Raquel ; Elvas, Filipe ; Madeira, Maria H. ; Aires, Inês D. ; Rodrigues-Neves, Ana C. ; Tralhão, Pedro ; Szabó, Eszter C; Baqi, Younis; Müller, Christa E. ; Tomé, Ângelo R. ; Cunha, Rodrigo A. ; Ambrósio, Francisco ; Santiago, Ana R. articleopenAccess